We are delighted to present the publication reporting our AVI-PDM™ model of breast cancers, and preclinical studies using our in vivo model conducted in collaboration with Erytech Pharma.
AVI-PDX™ for breast cancers
|Publié le : Jan 27, 2022||
We are delighted to present the publication reporting our AVI-PDM™ model of breast cancers, and preclinical studies using our in vivo model conducted in collaboration with Erytech Pharma.